Martha Moheb Morcoss

Dr. Martha Moheb Morcoss


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
Martha Moheb MorcossMartha Moheb Morcoss
Martha Moheb Morcoss
EAElshimaa Abdelhafez
Elshimaa Abdelhafez
RIReham A. Ibrahem
Reham A. Ibrahem
Hamdy M. Abdel-RahmanHamdy M. Abdel-Rahman
Hamdy M. Abdel-Rahman
MAMohamed Abdel-Aziz
Mohamed Abdel-Aziz
DEDalal A. Abou El-Ella
Dalal A. Abou El-Ella

16 January 2024 in Molecules
Verified
Journal Article
Open access
PDF file
BYBahaa G. M. Youssif
Bahaa G. M. Youssif
Martha Moheb MorcossMartha Moheb Morcoss
Martha Moheb Morcoss
SBStefan Bräse
Stefan Bräse
MAMohamed Abdel-Aziz
Mohamed Abdel-Aziz
Hamdy M. Abdel-RahmanHamdy M. Abdel-Rahman
Hamdy M. Abdel-Rahman
EAElshimaa Abdelhafez
Elshimaa Abdelhafez
A new class of benzimidazole-based derivatives (4a–j, 5, and 6) with potential dual inhibition of EGFR and BRAFV600E has been developed. The newly synthesized compounds were submitted for testing for antiproliferative activity against the NCI-60 cell line. All newly synthesized compounds 4a–j, 5, and 6 were selected for testing against a panel of sixty cancer cell lines at a single concentration of 10 µM. Some compounds tested demonstrated remarkable antiproliferative activity against the cell lines tested. Compounds 4c, 4e, and 4g were chosen for five-dose testing against 60 human tumor cell lines. Compound 4c demonstrated strong selectivity against the leukemia subpanel, with a selectivity ratio of 5.96 at the GI50 level. The most effective in vitro anti-cancer assay derivatives (4c, 4d, 4e, 4g, and 4h) were tested for EGFR and BRAFV600E inhibition as potential targets for antiproliferative action. The results revealed that compounds 4c and 4e have significant antiproliferative activity as dual EGFR/BRAFV600E inhibitors. Compounds 4c and 4e induced apoptosis by increasing caspase-3, caspase-8, and Bax levels while decreasing the anti-apoptotic Bcl2 protein. Moreover, molecular docking studies confirmed the potential of compounds 4c and 4e to act as dual EGFR/BRAFV600E inhibitors.

4 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Hany M. Abd El-LateefHany M. Abd El-Lateef
Hany M. Abd El-Lateef
MEMohammed A. I. Elbastawesy
Mohammed A. I. Elbastawesy
TITamer Mohamed Abdelghani Ibrahim
Tamer Mohamed Abdelghani Ibrahim
MKMai Khalaf
Mai Khalaf
Mohamed GoudaMohamed Gouda
Mohamed Gouda
Martha Moheb MorcossMartha Moheb Morcoss
Martha Moheb Morcoss
A new series of Schiff–benzimidazole hybrids 3a–o has been designed and synthesized. The structure of the target compounds was proved by different spectroscopic and elemental analysis tools. The target compounds were evaluated for their in vitro cytotoxic activity against 60 cancer cell lines according to NCI single- and five-dose protocols. Consequently, four compounds were further examined against the most sensitive lung cancer A549 and NCI-H460 cell lines. Compounds 3e and 3g were the most active, achieving 3.58 ± 0.53, 1.71 ± 0.17 and 1.88 ± 0.35, 0.85 ± 0.24 against A549 and NCI-H460 cell lines, respectively. Moreover, they showed remarkable inhibitory activity on the VEGFR-2 TK with 86.23 and 89.89%, respectively, as compared with Sorafenib (88.17%). Moreover, cell cycle analysis of NCI-H460 cells treated with 3e and 3g showed cellular cycle arrest at both G1 and S phases (supported by caspases-9 study) with significant pro-apoptotic activity, as indicated by annexin V-FITC staining. The binding interactions of these compounds were confirmed through molecular docking studies; the most active compounds displayed complete overlay with, and a similar binding mode and pose to, Sorafenib, a reference VEGFR-2 inhibitor.

11 February 2020 in Journal of advanced Biomedical and Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
Martha Moheb MorcossMartha Moheb Morcoss
Martha Moheb Morcoss
EAElshimaa Abdelhafez
Elshimaa Abdelhafez
HAHamdy M. Abdel-Rahman
Hamdy M. Abdel-Rahman
MAMohamed Abdel-Aziz
Mohamed Abdel-Aziz
DEDalal A. Abou El-Ella
Dalal A. Abou El-Ella
A novel series of benzimidazole-hydrazone derivatives was designed and synthesized as a potential anti-cancer agents. The structure of the target compounds was assured using different spectroscopic methods such as IR , 1H NMR, 13C NMR and elemental analysis. These new compounds were examined and evaluated for their antiproliferative activities against 60 different cell lines. Combination of benzimidazole scaffold with hydrazone group exhibited promising anti-cancer activity. Compounds 3a and 3b showed significant activity against different cancer cells lines between 50-84 % of growth inhibition. A molecular modeling study for compounds 3a and 3b into VEGFR-2 active site was performed with reasonable docking scores.

16 January 2025 in Bioorganic Chemistry
Verified
Journal Article
Closed access
Martha Moheb MorcossMartha Moheb Morcoss
Martha Moheb Morcoss
JSJakline Nelson Saddik
Jakline Nelson Saddik
MAMariam E. Amin
Mariam E. Amin
FMFatma A.M. Mohamed
Fatma A.M. Mohamed
AEAhmed A. El-Rashedy
Ahmed A. El-Rashedy
PLPhoebe F. Lamie
Phoebe F. Lamie

11 May 2017 in Journal of Chromatographic Science
Verified
Journal Article
Closed access
PDF file
Martha Moheb MorcossMartha Moheb Morcoss
Martha Moheb Morcoss
NANada S. Abdelwahab
Nada S. Abdelwahab
NANouruddin W. Ali
Nouruddin W. Ali
MEMohammed T. Elsaady
Mohammed T. Elsaady
Two sensitive, accurate and precise chromatographic methods mentioned as TLC-densitometric method and RP-HPLC-DAD method, were developed and validated for the simultaneous determination of mefenamic acid (MEF) and its two toxic impurities, benzoic acid (BA) and 2,3-dimethylaniline (DMA). In the proposed TLC-densitometric method a developing system consisting of chloroform:acetone:acetic acid:ammonia solution(70:30:2:2, v/v/v/v) was used, TLC aluminum plates 60 F254 was used as a stationary phase and the separated bands were UV-scanned at 225 nm. While the proposed RP-HPLC-DAD method depended on chromatographic separation on C18 column using 0.05 M KH2PO4 buffer: acetonitrile (40:60, v/v) as a mobile phase at constant flow rate of 1 mL/min with UV detection at 225 nm. Linear relationships were obtained in the ranges of 0.3–2, 0.3–2 and 0.3–1.8 μg/band (for TLC-densitometric method) and in the ranges of 7–50, 10–50 and 7–50 μg/mL (for HPLC-DAD method) for MEF, BA and DMA, respectively. Factors affecting the developed methods have been studied and optimized. Moreover ,the proposed methods were successfully applied for determination of the studied drug in its pharmaceutical dosage form. The methods showed no significance difference when compared with the reported method using F-test and Student's-t test. The low of detection and quantization limits of the proposed methods get them suitable for quality control and stability studies of MEF in pharmaceutical formulation. The developed methods have advantages of being more selective and sensitive than the published methods.